Alcon: all 719 studies

Page 3 of 8. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Gas Permeable Contact Lens WearersCompletedNCT01912781Not applicableResults posted
• Safety and Efficacy Evaluation of a New Contact Lens Disinfecting Solution in Soft Contact Lens WearersCompletedNCT01912768Not applicableResults posted
• Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy TubesTerminatedNCT01908803Phase 2Results posted
• A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular AdhesionCompletedNCT01889251Phase 3Results posted
• Nepafenac Once Daily for Macular Edema - Study 2CompletedNCT01872611Phase 3Results posted
• Lid Wiper Epitheliopathy TrialTerminatedNCT01870856Not applicableResults posted
• Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface StainingCompletedNCT01863368Not applicableResults posted
• Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery PatientsCompletedNCT01859702Phase 4Results posted
• Visual Performance Investigation of Two Toric Soft Contact LensesCompletedNCT01858701Not applicableResults posted
• Nepafenac Once Daily for Macular Edema - Study 1CompletedNCT01853072Phase 3Results posted
• ESBA1008 Microvolume StudyCompletedNCT01849692Phase 2Results posted
• Intra-Operative Metrics With CENTURION® and INFINITI® Vision SystemsCompletedNCT01848288Not applicableResults posted
• Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact LensesCompletedNCT01839318Not applicableResults posted
• Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular DegenerationCompletedNCT01835015Phase 1Results posted
• Efficacy and Safety Study of FID 119515ACompletedNCT01833117Not applicableResults posted
• Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting SolutionCompletedNCT01809197Not applicableResults posted
• Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact LensCompletedNCT01797783Not applicableResults posted
• Efficacy and Safety Study of ESBA1008 Versus EYLEA®CompletedNCT01796964Phase 2Results posted
• A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens WearersCompletedNCT01782482Not applicableResults posted
• Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic ConjunctivitisCompletedNCT01743027Phase 3Results posted
• SYSTANE® Family - Meibomian DeficiencyCompletedNCT01733745Not applicableResults posted
• SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory BiomarkersCompletedNCT01733732Not applicableResults posted
• Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01731002Phase 2Results posted
• The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye SubjectsCompletedNCT01718028Not applicableResults posted
• Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care SystemsCompletedNCT01699750Not applicableResults posted
• A Safety and Effectiveness Study of PRK Using the ALLEGRETTO WAVE® EYE-Q Excimer Laser SystemCompletedNCT01699087Not applicableResults posted
• A Six-Week Safety Study of an Investigational Ophthalmic SolutionCompletedNCT01698814Phase 3Results posted
• Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis PatientsCompletedNCT01697969Phase 4Results posted
• Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid DeficiencyCompletedNCT01688726Not applicableResults posted
• Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2CompletedNCT01684046Not applicableResults posted
• Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1CompletedNCT01684033Not applicableResults posted
• A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract PatientsCompletedNCT01684007Not applicableResults posted
• An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®CompletedNCT01664039Phase 4Results posted
• Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma PatientsCompletedNCT01658839Phase 1Results posted
• Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma PatientsCompletedNCT01652664Phase 3Results posted
• A Prospective Study of Two Daily Disposable Contact LensesCompletedNCT01636986Not applicableResults posted
• A Comparison of AIR OPTIX® COLORS Versus FRESHLOOK® COLORBLENDSCompletedNCT01635933Not applicableResults posted
• A Comparison of Silicone Hydrogel Contact Lenses: AIR OPTIX® COLORS Versus AIR OPTIX® AQUACompletedNCT01635920Not applicableResults posted
• Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact LensesCompletedNCT01634659Not applicableResults posted
• Determination of Cell Population in Solution-Induced Corneal Staining (SICS) and Symptomatic Versus Asymptomatic Lens WearersCompletedNCT01629706Not applicableResults posted
• Clinical Evaluation of Two Monthly Replacement Silicone Hydrogel Contact LensesCompletedNCT01629693Not applicableResults posted
• Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens WearersCompletedNCT01614600Not applicableResults posted
• AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0] in JapanCompletedNCT01605877Not applicableResults posted
• A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)TerminatedNCT01603043Phase 2Results posted
• An Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid TissuesCompletedNCT01594294Not applicableResults posted
• An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese PatientsCompletedNCT01573910Phase 3Results posted
• Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact LensesCompletedNCT01561560Not applicableResults posted
• Pre-Lens Tear Film Performance of Silicone Hydrogel Daily Disposable Contact LensesCompletedNCT01548833Not applicableResults posted
• Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON)CompletedNCT01539239Not applicableResults posted
• Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis ExternaCompletedNCT01535599Phase 3Results posted
• Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis ExternaCompletedNCT01535560Phase 3Results posted
• Study of AR-13324 in Patients With Elevated Intraocular PressureCompletedNCT01528787Phase 2Results posted
• Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin AmericaCompletedNCT01518244Phase 4Results posted
• Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in BrazilTerminatedNCT01514734Phase 4Results posted
• Clinical Investigation of AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0]CompletedNCT01510717Not applicableResults posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01510145Phase 4Results posted
• Long Term Safety Protocol for the AcrySof CACHET Phakic LensCompletedNCT01497067Not applicableResults posted
• Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid TissuesCompletedNCT01494818Not applicableResults posted
• Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens WearersCompletedNCT01494545Not applicableResults posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01493427Phase 4Results posted
• AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular PressureCompletedNCT01484951Phase 4Results posted
• Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens WearersCompletedNCT01484938Not applicableResults posted
• Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity ChamberCompletedNCT01482312Not applicableResults posted
• Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) ModelCompletedNCT01479374Phase 3Results posted
• Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)CompletedNCT01476722Not applicableResults posted
• Daily Disposable Contact Lens Tear Film StudyCompletedNCT01473160Not applicableResults posted
• Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)CompletedNCT01464424Phase 4Results posted
• Prospective Study of an Investigational Toric Soft Contact LensCompletedNCT01461811Not applicableResults posted
• Safety and Efficacy of AL-53817 Nasal Spray SolutionCompletedNCT01454505Phase 1Results posted
• Travoprost 3-Month Safety and Efficacy StudyCompletedNCT01453855Phase 3Results posted
• A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young PatientsCompletedNCT01445652Not applicableResults posted
• AIR OPTIX® COLORS Registration TrialCompletedNCT01440322Not applicableResults posted
• Lens Wear Schedules and End-of-Day ComfortCompletedNCT01433549Not applicableResults posted
• A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%CompletedNCT01426867Phase 2Results posted
• Nepafenac Compared to Placebo for Ocular Pain and InflammationCompletedNCT01426854Phase 3Results posted
• Clinical Investigation of AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL)CompletedNCT01424189Not applicableResults posted
• Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue CompressionCompletedNCT01423773Not applicableResults posted
• Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in CanadaCompletedNCT01415401Phase 4Results posted
• Evaluation of the Cosmetic Performance of AIR OPTIX® COLORSCompletedNCT01398787Not applicableResults posted
• Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye SyndromeCompletedNCT01382225Phase 3Results posted
• Study of the Cell Response in the Tear Film After Overnight Contact Lens WearCompletedNCT01379768Not applicableResults posted
• Performance Evaluation of a New Daily Disposable Silicone Hydrogel LensCompletedNCT01371552Not applicableResults posted
• Clinical Comparison of Two Multifocal Contact Lenses Made of Silicone Hydrogel MaterialsCompletedNCT01371539Not applicableResults posted
• Clinical Comparison of Silicone Hydrogel and HEMA-based Daily Disposable Contact LensesCompletedNCT01362907Not applicableResults posted
• Clinical Comparison of Two Daily Disposable Toric LensesCompletedNCT01362894Not applicableResults posted
• Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01357616Phase 3Results posted
• Effect of FID 114675A on Lens WettabilityCompletedNCT01342107Not applicableResults posted
• Effect of an Investigational Multi-Purpose Solution on Lens MoistureCompletedNCT01341990Not applicableResults posted
• Safety and Efficacy of an Investigational Multi-Purpose Disinfecting SolutionCompletedNCT01341977Not applicableResults posted
• Patient Preference Comparison of AZARGA Versus COSOPTCompletedNCT01340014Phase 4Results posted
• ESBA105 in Patients With Severe Dry EyeCompletedNCT01338610Phase 2Results posted
• Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololCompletedNCT01336569Phase 4Results posted
• Efficacy of Changing to DUOTRAV® From Prior TherapyCompletedNCT01327599Phase 4Results posted
• AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL) Clinical Study in JapanCompletedNCT01323777Not applicableResults posted
• Nepafenac 0.3% Two StudyCompletedNCT01318499Phase 2Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01310777Phase 3Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01309204Phase 3Results posted
• ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) PatientsCompletedNCT01304693Phase 1/2Results posted
• Four Week Performance Comparison Between Two Commercially Available Silicone Hydrogel LensesCompletedNCT01300767Not applicableResults posted
• One Month Performance Comparison Between Two Commercially Available Silicone Hydrogel LensesCompletedNCT01300741Not applicableResults posted

← Alcon overview and focus areas